The Basic Advocacy Training SessionThe training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.
|
The Basic Advocacy Training SessionThe training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.
|
FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…
Education Series Number 4 August 1994 Methadone, HIV Infection and Immune Function by Herman Joseph Studies undertaken over the past two decades, primarily by Dr. Mary Jeanne Kreek of The Rockefeller University, and corroborated by other scientists throughout the world have established the long-term medical safety of methadone maintenance treatment (Kreek, 1992; Kreek, 1987; Kreek,…
WELCOME TO “METHADONE SPOKEN HERE” NAMA’s NEW Web Discussion Forum Home This is an on-line discussion forum called Methadone Spoken Here. The contents frame shows the titles of all articles posted to the discussion. Selecting a title will cause the corresponding article to be loaded into this frame. You may also: Post a new article…
Changes in Methadone Treatment Practices: Results From a National Panel Study, 1988-2000 by Thomas D’Aunno, PhD; Harold A. Pollack, PhD Journal of the American Medical Association Vol. 288, No. 7 August 21, 2002 Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use…
Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…
Fifteen Years ago when NAMA first started, methadone advocacy was a few committed individuals who all knew one another. When on those rare occasions that new advocate became active she or he was mentored by a more experienced advocate. A few mistakes were made but the same mistake was seldom made twice. The result of…